Myriad Genetics (MYGN) Misses Q2 EPS by 3c; Offers 3Q & FY19 EPS/Revenue Outlook
Go back to Myriad Genetics (MYGN) Misses Q2 EPS by 3c; Offers 3Q & FY19 EPS/Revenue Outlook| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.50 | 52 Week High | $45.34 | |||
| Open | $4.50 | 52 Week Low | $15.92 | |||
| Day High | $4.50 | P/E | 1.93 | |||
| Day Low | $4.50 | EPS | $2.33 | |||
| Volume | 20 | |||||
